Vanda Pharmaceuticals (VNDA) Treasury Shares (2009 - 2026)

Vanda Pharmaceuticals has disclosed Treasury Shares across 18 years of filings, most recently posting $4.2 million for Q1 2026.

• Treasury Shares for Q1 2026 came in at $4.2 million, up 26.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.2 million (up 26.67% YoY), and the FY2025 annual result was $3.5 million, up 31.19% from the prior year.
• Treasury Shares came in at $4.2 million for Q1 2026 at Vanda Pharmaceuticals, up from $3.5 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $4.2 million in Q1 2026 to a low of $1.9 million in Q4 2023.
• The 5-year median for Treasury Shares is $2.7 million (2024), against an average of $2.6 million.
• Across the five-year window, Treasury Shares decreased 2.33% in 2023 and surged 42.05% in 2024, its largest moves.
• Vanda Pharmaceuticals' Treasury Shares stood at $1.9 million in 2022, then dropped by 0.53% to $1.9 million in 2023, then jumped by 39.09% to $2.7 million in 2024, then surged by 31.19% to $3.5 million in 2025, then rose by 21.49% to $4.2 million in 2026.
• The last three Treasury Shares figures came in at $4.2 million (Q1 2026), $3.5 million (Q4 2025), and $3.5 million (Q3 2025), per Business Quant data.